|
End-of-day quote
Euronext Amsterdam
|
||
| - EUR | - |
|
| 08-13 | Pharming Launches Joenja in Japan for Adult, Pediatric APDS Patients | MT |
| 08-13 | Pharming Group Launches Rare Primary Immunodeficiency Therapy Joenja in Japan | MT |
Upcoming events on PHARMING GROUP
| 05/11/2026 | Earnings release - Q3 2026 |
Past events on PHARMING GROUP
| 30/07/2026 | Earnings presentation | 12:30 |
| 30/07/2026 | Earnings release - Q2 2026 | |
| 28/05/2026 | Annual General Meeting | 13:00 |
| 28/05/2026 | Présentation aux Actionnaires / Analystes | 13:00 |
| 07/05/2026 | Earnings presentation | 12:30 |
| 07/05/2026 | Earnings release - Q1 2026 | |
| 12/03/2026 | Earnings presentation | 12:30 |
| 12/03/2026 | Earnings release - Q4 2025 | |
| 03/02/2026 | Analyst/Investor Day | 15:00 |
| 06/11/2025 | Earnings release - Q3 2025 | |
| 06/11/2025 | Earnings presentation | 12:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 245 245 0.07% | 297 286 3.74% | 376 376 0.04% | 383 | 425 | 426 |
|
EBITDA Million USD | Released Forecast Spread | 10,5 2,65 297.66% | 7,45 4,25 75.27% | 37,1 41,5 -10.8% | 48,7 | 76,5 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,39 -8,15 33.87% | -8,62 -10,00 13.75% | 25,8 34,1 -24.12% | 16,7 | 29,4 | 33,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,0 -5,53 -117.2% | -8,51 -10,2 16.71% | 12,8 18,8 -31.51% | 24,5 | 35,2 | 35,1 |
|
Net income Million USD | Released Forecast Spread | -10,1 -4,03 -151.07% | -11,0 -10,9 -1.1% | 2,85 4,55 -37.39% | 21,0 | 29,6 | 31,7 |
|
EPS USD | Released Forecast Spread | -0,02 -0,01 -50% | -0,02 -0,02 7.89% | 0,00 0,00 66.67% | 0,04 | 0,03 | 0,02 |
| Announcement Date | 14/03/24 | 13/03/25 | 12/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 92,7 81,3 14.09% | 79,1 64,0 23.58% | 93,2 82,6 12.82% | 97,3 91,7 6.08% | 107 105 1.12% | 72,4 92,1 -21.31% | 90,2 99,5 -9.35% | 163 183 -11.24% | 104 | 115 | 76,0 | 94,5 | 104 | 118 |
|
EBIT Million USD | Released Forecast Spread | 6,70 5,48 22.23% | -7,04 -18,1 61.08% | 10,8 -0,60 1908.17% | 15,8 5,80 172.81% | 6,20 12,9 -51.75% | -4,91 4,00 -222.78% | 1,31 6,90 -80.96% | 10,5 | 15,1 | -10,2 | -2,30 | 0,30 | 10,2 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6,60 5,53 19.28% | -11,8 -13,9 14.89% | 7,08 -6,60 207.26% | 12,8 5,00 155.16% | 4,80 10,6 -54.72% | -4,75 3,83 -223.99% | 3,04 15,6 -80.46% | -1,71 19,3 -108.88% | 12,3 | 16,4 | -9,20 | -1,30 | 1,30 | 11,2 |
|
Net income Million USD | Released Forecast Spread | 3,70 3,83 -3.48% | -14,7 -14,1 -4.39% | 4,69 -8,20 157.24% | 7,55 3,35 125.31% | 5,33 6,67 -20.08% | -5,21 2,30 -326.65% | 1,64 14,3 -88.55% | -3,58 18,1 -119.75% | 11,9 | 15,7 | -6,90 | -1,00 | 0,90 | 8,40 |
|
EPS USD | Released Forecast Spread | 0,01 0,00 - | 0,01 0,00 - | 0,01 | 0,02 | -0,01 | 0,00 | 0,00 | 0,01 | ||||||
| Announcement Date | 13/03/25 | 08/05/25 | 31/07/25 | 06/11/25 | 12/03/26 | 07/05/26 | 30/07/26 | 30/07/26 | - | - | - | - | - | - |
| 31/08/2026 | Earnings release - Q2 2026 | ||
| 31/08/2026 | Significant Split/Dividend | 05:00 | |
| 31/08/2026 | Earnings release - Q2 2026 | ||
| 31/08/2026 | Earnings release - Q2 2026 | ||
| 31/08/2026 | Board of Directors Meeting | ||
| 31/08/2026 | Significant Split/Dividend | 05:00 | |
| 31/08/2026 | Ex-dividend date - 2.56532 TWD | 05:00 | |
| 31/08/2026 | Earnings release - Q2 2026 | ||
| 31/08/2026 | Extraordinary General Meeting | ||
| 31/08/2026 | Présentation aux Actionnaires / Analystes | 04:00 |
Past sector events for PHARMING GROUP
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 | ||
| 29/08/2026 | Earnings release - Q2 2026 |
- Stock Market
- Stocks
- PHARM Stock
- Stock
- Calendar PHARMING GROUP
Select your edition
All financial news and data tailored to specific country editions
















